These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19116413)

  • 1. Psychometric properties of teacher SKAMP ratings from a community sample.
    Murray DW; Bussing R; Fernandez M; Wei Hou ; Garvan CW; Swanson JM; Eyberg SM
    Assessment; 2009 Jun; 16(2):193-208. PubMed ID: 19116413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
    Biederman J; Wigal SB; Spencer TJ; McGough JJ; Mays DA
    Clin Ther; 2006 Feb; 28(2):280-93. PubMed ID: 16678649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, crossover study of once-daily dexmethylphenidate in children with attention-deficit hyperactivity disorder: rapid onset of effect.
    Brams M; Muniz R; Childress A; Giblin J; Mao A; Turnbow J; Borrello M; McCague K; Lopez FA; Silva R
    CNS Drugs; 2008; 22(8):693-704. PubMed ID: 18601306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms: psychometric properties and normative ratings from a school district sample.
    Bussing R; Fernandez M; Harwood M; Wei Hou ; Garvan CW; Eyberg SM; Swanson JM
    Assessment; 2008 Sep; 15(3):317-28. PubMed ID: 18310593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender Effects in the Efficacy of Racemic Amphetamine Sulfate in Children with Attention-Deficit/Hyperactivity Disorder.
    Childress AC; Newcorn JH; Cutler AJ
    Adv Ther; 2019 Jun; 36(6):1370-1387. PubMed ID: 30972657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day.
    Faraone SV; Childress AC; Gomeni R; Rafla E; Kando JC; Dansie L; Naik P; Pardo A
    J Child Adolesc Psychopharmacol; 2023 Feb; 33(1):14-19. PubMed ID: 36730749
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevalence of and screening for ADHD in Costa Rica].
    Berrocal M; Peskin V; Weiss N; Schuler J; Monge S; McGough JJ; Chavira D; Bagnarello M; Herrera LD; Mathews CA
    Vertex; 2011; 22(99):337-42. PubMed ID: 22432094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability of a Web-based attention-deficit/hyperactivity disorder scale (T-SKAMP) by teachers: a pilot study.
    Bhatara VS; Vogt HB; Patrick S; Doniparthi L; Ellis R
    J Am Board Fam Med; 2006; 19(2):195-200. PubMed ID: 16513909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parent SNAP-IV rating of attention-deficit/hyperactivity disorder: accuracy in a clinical sample of ADHD, validity, and reliability in a Brazilian sample.
    Costa DS; de Paula JJ; Malloy-Diniz LF; Romano-Silva MA; Miranda DM
    J Pediatr (Rio J); 2019; 95(6):736-743. PubMed ID: 30236592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.
    Childress AC; Kollins SH; Cutler AJ; Marraffino A; Sikes CR
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):66-74. PubMed ID: 27183299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parent and teacher ratings of attention-deficit/hyperactivity disorder symptoms: Factor structure and normative data.
    DuPaul GJ; Reid R; Anastopoulos AD; Lambert MC; Watkins MW; Power TJ
    Psychol Assess; 2016 Feb; 28(2):214-25. PubMed ID: 26011476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day.
    Wigal SB; Kollins SH; Childress AC; Adeyi B
    Child Adolesc Psychiatry Ment Health; 2010 Dec; 4():32. PubMed ID: 21156071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-release dexmethylphenidate 30 mg/d versus 20 mg/d: duration of attention, behavior, and performance benefits in children with attention-deficit/hyperactivity disorder.
    Silva RR; Brams M; McCague K; Pestreich L; Muniz R
    Clin Neuropharmacol; 2013; 36(4):117-21. PubMed ID: 23860345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder.
    Childress AC; Wigal SB; Brams MN; Turnbow JM; Pincus Y; Belden HW; Berry SA
    J Child Adolesc Psychopharmacol; 2018 Jun; 28(5):306-313. PubMed ID: 29211967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder.
    Silva RR; Muniz R; Pestreich L; Brams M; Mao AR; Childress A; Wang J
    J Am Acad Child Adolesc Psychiatry; 2008 Feb; 47(2):199-208. PubMed ID: 18176337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofeedback and cognitive attention training for children with attention-deficit hyperactivity disorder in schools.
    Steiner NJ; Frenette EC; Rene KM; Brennan RT; Perrin EC
    J Dev Behav Pediatr; 2014 Jan; 35(1):18-27. PubMed ID: 24399101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder.
    Silva RR; Muniz R; Pestreich L; Childress A; Brams M; Lopez FA; Wang J
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):239-51. PubMed ID: 16768632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric properties of Japanese version of the Swanson, Nolan, and Pelham, version-IV Scale-Teacher Form: a study of school children in community samples.
    Inoue Y; Ito K; Kita Y; Inagaki M; Kaga M; Swanson JM
    Brain Dev; 2014 Sep; 36(8):700-6. PubMed ID: 24075708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder.
    Childress AC; Kando JC; King TR; Pardo A; Herman BK
    J Child Adolesc Psychopharmacol; 2019 Feb; 29(1):2-8. PubMed ID: 30575407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical measure of impairment: psychometric properties of the impairment rating scale in samples of children with attention deficit hyperactivity disorder and two school-based samples.
    Fabiano GA; Pelham WE; Waschbusch DA; Gnagy EM; Lahey BB; Chronis AM; Onyango AN; Kipp H; Lopez-Williams A; Burrows-Maclean L
    J Clin Child Adolesc Psychol; 2006 Sep; 35(3):369-85. PubMed ID: 16836475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.